Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor version bump. This update aligns with backend or template changes rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T01:00:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's disease label 'Multiple myeloma' and the related topics section, including the MedlinePlus Genetics link, were removed, reducing disease-specific context and cross-references.
    Difference
    0.2%
    Check dated 2026-08-01T01:13:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a backend/platform update. This change does not alter the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-24T22:12:34.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.2 to v3.6.3. This represents a small update to the page metadata and does not alter displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T13:50:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend update to the page. This does not alter study details or visible content.
    Difference
    0.1%
    Check dated 2026-06-26T09:47:44.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    New study-record navigation items have been added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading has been standardized. A banner now shows No longer looking for participants, and the revision/version is updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-11T23:29:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.